Clinical significance of serum angiocidin levels in hepatocellular carcinoma.

@article{Sabherwal2007ClinicalSO,
  title={Clinical significance of serum angiocidin levels in hepatocellular carcinoma.},
  author={Yamini Sabherwal and Vicki L. Rothman and Ronnie Tung-ping Poon and George P. Tuszynski},
  journal={Cancer letters},
  year={2007},
  volume={251 1},
  pages={28-35}
}
Angiocidin, a tumor-secreted protein, was measured in serum of 27 healthy volunteers and 33 hepatocellular carcinoma (HCC) patients. Healthy controls either hepatitis B surface antigen (HBsAg) positive or negative showed undetectable levels. Patients had levels of angiocidin ranging from 15.09 to 195.73 pg/ml. Patients with stages III-IV had higher levels of angiocidin (97+/-13 pg/ml, n=17) compared to those with stages I-II (63+/-37 pg/ml, n=16), p<0.043. Patients with microsatellite tumor… CONTINUE READING